MARKET

NTRB

NTRB

Nutriband Inc
NASDAQ
5.39
+0.19
+3.65%
Closed 19:41 06/24 EDT
OPEN
5.18
PREV CLOSE
5.20
HIGH
5.43
LOW
5.11
VOLUME
16.96K
TURNOVER
0
52 WEEK HIGH
6.75
52 WEEK LOW
1.530
MARKET CAP
59.48M
P/E (TTM)
-7.0550
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at NTRB last week (0617-0621)?
Weekly Report · 21h ago
Weekly Report: what happened at NTRB last week (0610-0614)?
Weekly Report · 06/17 11:51
Weekly Report: what happened at NTRB last week (0603-0607)?
Weekly Report · 06/10 11:54
Weekly Report: what happened at NTRB last week (0527-0531)?
Weekly Report · 06/03 11:57
Weekly Report: what happened at NTRB last week (0520-0524)?
Weekly Report · 05/27 12:03
Weekly Report: what happened at NTRB last week (0513-0517)?
Weekly Report · 05/20 11:54
Nutriband Inc Bolsters Board with Experienced Commercial Director
TipRanks · 05/17 10:14
GoodRx Holdings, Seelos Therapeutics, Clever Leaves among healthcare movers
Healthcare On the Move: GoodRx Holdings, Seelos Therapeutics, Clever Leaves among healthcare movers. S&P 500 Health Care Sector contributes 58% to index. Health Care Equipment & Services and Services are among the top three sectors in the index.
Seeking Alpha · 05/16 14:00
More
About NTRB
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

Webull offers Nutriband Inc stock information, including NASDAQ: NTRB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTRB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NTRB stock methods without spending real money on the virtual paper trading platform.